MAP2K4 and Parkinson disease: Shakespear et al. reported that ADEVs contain high levels of miR-200a-3p which targets the 3’-untranslated region (UTR) of Map2k4 and MKK4 mRNA, therefore inhibiting the c-Jun N-terminal kinase cell death pathway in an in vitro model of PD [129].